Efflux inhibition with verapamil potentiates bedaquiline in Mycobacterium tuberculosis
- PMID: 24126586
- PMCID: PMC3910722
- DOI: 10.1128/AAC.01462-13
Efflux inhibition with verapamil potentiates bedaquiline in Mycobacterium tuberculosis
Abstract
Drug efflux is an important resistance mechanism in Mycobacterium tuberculosis. We found that verapamil, an efflux inhibitor, profoundly decreases the MIC of bedaquiline and clofazimine to M. tuberculosis by 8- to 16-fold. This exquisite susceptibility was noted among drug-susceptible and drug-resistant clinical isolates. Thus, efflux inhibition is an important sensitizer of bedaquiline and clofazimine, and efflux may emerge as a resistance mechanism to these drugs.
References
-
- World Health Organization 2013. Multidrug-resistant tuberculosis (MDR-TB) 2013 update. World Health Organization, Geneva, Switzerland
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
